Ntla stock price target
NTLA | Intellia Therapeutics Inc. Analyst Estimates ... Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. Intellia Therapeutics, Inc. Common Stock (NTLA) Stock ... Feb 27, 2020 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Intellia Therapeutics, Inc. (NTLA) Stock Forum ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Intellia Therapeutics - NTLA - Stock Price & News | The ...
View live CRISPR THERAPEUTICS AG chart to track its stock's price action. Find market predictions, CRSP financials and market news. Look for $65 target in next month and then back up to $75. Trade with caution. There is a 6% short interest on this. Not considered high, but not nothing. CRSPR technology is the future.
The 10 analysts offering 12-month price forecasts for Intellia Therapeutics Inc The current consensus among 11 polled investment analysts is to Buy stock in Their average twelve-month price target is $26.42, suggesting that the stock has a possible upside of 120.32%. The high price target for NTLA is $57.50 and the 8 brokerages have issued 12-month price targets for Intellia Therapeutics' stock. Their forecasts range from $16.00 to $57.50. On average, they anticipate Intellia Based on 4 analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $31.83 with a high forecast of
NTLA Intellia Therapeutics, Inc. daily Stock Chart Book/sh, 5.47, P/B, 2.32, EPS next Y, -11.40%, ROA, -28.90%, Target Price, 25.75, Perf Year, -30.96%. Cash/
Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. NTLA Intellia Therapeutics, Inc. daily Stock Chart Book/sh, 5.47, P/B, 2.32, EPS next Y, -11.40%, ROA, -28.90%, Target Price, 25.75, Perf Year, -30.96%. Cash/ Information about which ETFs are holding the stock NTLA, Intellia in which CRISPR/Cas9 is the therapy, delivered to target cells within the body; and ex vivo 28 Feb 2020 NTLA Stock saw the intraday high of $12.39 and lowest of $11.16 per share. Analysis on target price and performance of stocks is usually Trade NTLA stock for free with recommended broker TD Ameritrade. Wedbush Downgrades Intellia Therapeutics to Neutral, Lowers Price Target to $16 Vick Prev Close 12.71, 52 Wk Low 9.18. Open 13.03, 52 Wk High 19.00. Day Low 12.00, Volume 446,939.00. Day High 13.09, Avg 10D Vol 555,064.00 NTLA, $NTLA, Intellia Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis
Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 25.75
NTLA -- Is Its Stock Price A Worthy Investment? Learn More. NTLA Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for NTLA is 0.15 -- better than just 12.33% of US stocks. The ratio of debt to operating expenses for Intellia Therapeutics Inc is higher than it is for about only 10.63% of US stocks. Intellia Therapeutics’ (NTLA) Buy Rating Reaffirmed at ...
18 Mar 2020 to bring smile on the investors face as Analysts sets mean Target price of $25.75 The 1-year high price for the company's stock is recorded $19.00 on Intellia Therapeutics, Inc. (NTLA) full year performance was -30.70%.
Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. NTLA Intellia Therapeutics, Inc. daily Stock Chart Book/sh, 5.47, P/B, 2.32, EPS next Y, -11.40%, ROA, -28.90%, Target Price, 25.75, Perf Year, -30.96%. Cash/ Information about which ETFs are holding the stock NTLA, Intellia in which CRISPR/Cas9 is the therapy, delivered to target cells within the body; and ex vivo 28 Feb 2020 NTLA Stock saw the intraday high of $12.39 and lowest of $11.16 per share. Analysis on target price and performance of stocks is usually Trade NTLA stock for free with recommended broker TD Ameritrade. Wedbush Downgrades Intellia Therapeutics to Neutral, Lowers Price Target to $16 Vick
Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. Intellia Therapeutics, Inc. Common Stock (NTLA) Stock ... Feb 27, 2020 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Intellia Therapeutics, Inc. (NTLA) Stock Forum ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Intellia Therapeutics - NTLA - Stock Price & News | The ...